Bimal R. Shah - 04 Apr 2025 Form 4 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role
Director
Signature
/s/ Bimal R. Shah
Issuer symbol
ANEB
Transactions as of
04 Apr 2025
Net transactions value
$0
Form type
4
Filing time
07 Apr 2025, 21:41:38 UTC
Previous filing
17 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANEB Stock Option (right to buy) Award $0 +25,000 $0.000000 25,000 04 Apr 2025 Common Stock 25,000 $1.02 Direct F1
transaction ANEB Stock Option (right to buy) Award $0 +6,618 $0.000000 6,618 04 Apr 2025 Common Stock 6,618 $1.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests on the earlier of April 4, 2026 or the date of the 2026 annual meeting of shareholders.

Remarks:

Exhibit List: Exhibit 24.1 - Power of Attorney (Bimal R. Shah)